Media coverage during April 2020
On 2 April 2020, the first in a series of papers describing long-term RCT outcomes of TARGIT-IORT for breast cancer was published.
Jayant S. Vaidya, Max Bulsara, Christobel Saunders, Henrik Flyger, Jeffrey S. Tobias, Tammy Corica, Samuele Massarut, Frederik Wenz, Steffi Pigorsch, Michael Alvarado, Michael Douek, Wolfgang Eiermann, Chris Brew-Graves MSc, Norman Williams, Ingrid Potyka, Nicholas Roberts, Marcelle Bernstein , Douglas Brown, Elena Sperk, Siobhan Laws, Marc Sütterlin, Steinar Lundgren, Dennis Holmes, Lorenzo Vinante, Fernando Bozza, Montserrat Pazos, Magali Le Blanc-Onfroy, Günther Gruber, Wojciech Polkowski, Konstantin J. Dedes, Marcus Niewald, Jens Blohmer, David McCready, Richard Hoefer, Pond Kelemen, Gloria Petralia, Mary Falzon, Michael Baum, David Joseph
JAMA Oncol. doi:10.1001/jamaoncol.2020.0249
This paper concludes "Based on the randomized evidence of immediate TARGIT-IORT, which has been shown to be an effective alternative to EBRT, it is clear that the preferred timing of using TARGIT-IORT is immediately - during the initial surgical excision of breast cancer. However, when immediate TARGIT-IORT has not been possible, the long-term data presented in this article [describing the results of the randomised trial of Delayed second-procedure single-dose intraoperative radiotherapy vs Whole breast external beam radiotherapy (EBRT) given over 3-6 weeks] may help inform discussions by clinicians and patients who wish to avoid a prolonged postoperative course of EBRT"
#breastcancer hashtag#radiotherapy hashtag#cancer hashtag#surgery hashtag#oncology
It was covered in the following medical news outlets / Blogs
2 April 2020 MedicalResearch.com, by Marie Benz MD FAAD
3 April 2020 MDLinx, Journal Summaries in Oncology
4 April 2020 Oncology Learning Network, by Hina Porcelli
15 April 2020 The ASCO Post, by Matthew Stenger
16 April 2020 Cancer Network, by Matthew Fowler